↓ Skip to main content

CD44 as a tumor biomarker and therapeutic target

Overview of attention for article published in Experimental Hematology & Oncology, December 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
193 Dimensions

Readers on

mendeley
206 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CD44 as a tumor biomarker and therapeutic target
Published in
Experimental Hematology & Oncology, December 2020
DOI 10.1186/s40164-020-00192-0
Pubmed ID
Authors

Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 206 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 11%
Researcher 22 11%
Student > Bachelor 19 9%
Student > Master 18 9%
Student > Doctoral Student 7 3%
Other 26 13%
Unknown 91 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 30 15%
Medicine and Dentistry 26 13%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Immunology and Microbiology 10 5%
Agricultural and Biological Sciences 9 4%
Other 24 12%
Unknown 95 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2021.
All research outputs
#14,039,778
of 23,270,775 outputs
Outputs from Experimental Hematology & Oncology
#108
of 304 outputs
Outputs of similar age
#254,570
of 508,412 outputs
Outputs of similar age from Experimental Hematology & Oncology
#4
of 10 outputs
Altmetric has tracked 23,270,775 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 304 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 508,412 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.